Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications
about
Immunotherapy of Childhood SarcomasThe role of myeloid-derived suppressor cells in immune ontogenyArsenic trioxide inhibits tumor-induced myeloid-derived suppressor cells and enhances T-cell activity.Potential of extravasated platelet aggregation as a surrogate marker for overall survival in patients with advanced gastric cancer treated with preoperative docetaxel, cisplatin and S-1: a retrospective observational studyTumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophagesImmune evasion mediated by tumor-derived lactate dehydrogenase induction of NKG2D ligands on myeloid cells in glioblastoma patients.Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanomaComplexity and challenges in defining myeloid-derived suppressor cellsThe induction of human myeloid derived suppressor cells through hepatic stellate cells is dose-dependently inhibited by the tyrosine kinase inhibitors nilotinib, dasatinib and sorafenib, but not sunitinib.Nanoparticle delivery of CDDO-Me remodels the tumor microenvironment and enhances vaccine therapy for melanoma.Fundamental Principles of Cancer Biology: Does it have relevance to the perioperative period?Synergistic immunotherapeutic effects of Lycium barbarum polysaccharide and interferon-α2b on the murine Renca renal cell carcinoma cell line in vitro and in vivo.Circulating Myeloid-Derived Suppressor Cells Predict Differentiated Thyroid Cancer Diagnosis and ExtentImmunomodulatory effect of captopril and local irradiation on myeloid-derived suppressor cells.The B-cell tumor promoter Bcl-3 suppresses inflammation-associated colon tumorigenesis in epithelial cells.Prognostic potential of an immune score based on the density of CD8+ T cells, CD20+ B cells, and CD33+/p-STAT1+ double-positive cells and HMGB1 expression within cancer nests in stage IIIA gastric cancer patients.Pseudomonas aeruginosa Airway Infection Recruits and Modulates Neutrophilic Myeloid-Derived Suppressor Cells.Mechanisms of tumor-induced T cell immune suppression and therapeutics to counter those effects.Chimeric antigen receptors and bispecific antibodies to retarget T cells in pediatric oncology.A comprehensive genome-wide analysis of melanoma Breslow thickness identifies interaction between CDC42 and SCIN genetic variantsEnhancing the efficacy of adoptive cellular therapy by targeting tumor-induced immunosuppression.Myeloid-Derived Suppressor Cells and Therapeutic Strategies in Cancer.Myeloid-derived suppressor cells: Important contributors to tumor progression and metastasis.Overcoming resistance to HER2-targeted therapy with a novel HER2/CD3 bispecific antibody.High immunosuppressive burden in cancer patients: a major hurdle for cancer immunotherapy.The pattern of GPI-80 expression is a useful marker for unusual myeloid maturation in peripheral blood.Biomarkers associated with checkpoint inhibitors.Tumor-Associated Macrophages and Myeloid-Derived Suppressor Cells as Immunosuppressive Mechanism in Ovarian Cancer Patients: Progress and Challenges.Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy.Interleukin-17A deficiency ameliorates streptozotocin-induced diabetes.Myeloid-derived suppressor cells are increased and correlated with type 2 immune responses, malnutrition, inflammation, and poor prognosis in patients with breast cancer.Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells.Inflammation, cytokines, the IL-17/IL-6/STAT3/NF-κB axis, and tumorigenesis.Myeloid-Derived Suppressor Cell Subset Accumulation in Renal Cell Carcinoma Parenchyma Is Associated with Intratumoral Expression of IL1β, IL8, CXCL5, and Mip-1α.High frequency of mononuclear myeloid-derived suppressor cells is associated with exacerbation of inflammatory bowel disease.Small GTPase RBJ promotes cancer progression by mobilizing MDSCs via IL-6.Topical treatment of all-trans retinoic acid inhibits murine melanoma partly by promoting CD8+ T-cell immunity.IL-4Rα aptamer-liposome-CpG oligodeoxynucleotides suppress tumour growth by targeting the tumour microenvironment.Immune Protection against Lethal Fungal-Bacterial Intra-Abdominal Infections.Janus-Faced Myeloid-Derived Suppressor Cell Exosomes for the Good and the Bad in Cancer and Autoimmune Disease.
P2860
Q26795369-E70167AE-24F0-4045-9FBD-28F88CB3675DQ28654584-325DE2C7-C9EA-4E4D-8665-AF8BD70D3B1CQ33598739-D74C5D53-03EE-43BF-8A15-983BE88C47CAQ33612711-83D88206-A267-42CF-8FA4-7902CC04AF40Q34044797-2BD197D6-7333-49E6-A59F-5255DD9F55AFQ34144695-C6B601BE-652B-4049-940F-ACFF9B68D7E0Q35078852-4200E4EE-6EA1-41A0-B66C-AFBDCDD480CEQ35509317-E8B98EBC-EC15-4F18-A45D-0993F8FDC1FAQ35898395-E146B95E-6E2C-417A-A7D5-BD53A8C14061Q35999941-A4B3125B-4758-4483-89F0-8A71965B4E9EQ36062109-F1EFB701-3DFA-4EA6-B54B-30511F536E1EQ36224768-470CD134-BECE-4D4C-825C-70D550370947Q36683267-539C99F4-5393-4F12-96C8-019868634B5BQ37343451-7A8A5BE6-A603-4D3C-8B9D-6846676CBFEDQ37389415-97491F12-9FC5-4789-B458-544C860D492FQ37402113-670BBCC5-F2CD-4478-9119-4C5732CC215DQ37447209-17613E29-7D99-485E-88A1-96568B783AABQ38336989-999A6F38-72FD-4DF1-ADB4-7AB53CB171B4Q38400420-86D33613-F443-4F6A-A622-287234CC5DC6Q38445526-26CDBD17-AB9F-4029-92DC-3C4E55598CE8Q38525024-09F78A65-DF22-4044-9129-FD2763DD13AFQ38528814-57C15006-4922-4DCD-883C-3183B89DC308Q38702891-292A86A5-9CAF-4BB4-83E1-B870B42B89C0Q38707896-B37CE051-BA90-4866-8178-CC1571E65445Q38748299-5F7429C4-8418-40A5-8F1C-7D890C2C5DBEQ38749477-70839491-C429-4010-AE89-EDEA90BE4F72Q38819537-D99FE3B0-2B3F-4CB6-BBB4-812A9DF5746EQ38958680-2BC23B7D-972F-4CE0-8F07-C25B6EB3838FQ39313889-6932931F-5777-4CAE-853D-76400D35F25CQ40695658-3223DB23-81D6-4854-85A2-6FE7D518FBD4Q41143084-04832ACD-80F1-4F4A-B4A4-7DEE4241B448Q41974388-B551BB71-60D7-4B7D-AFB0-9B62D975341AQ42432514-A3CED5D9-2231-4D80-8F99-0793AA539F55Q43100151-1F28132E-C459-4942-AE8E-9116DB950C85Q43583186-8E9812C3-B166-43E9-9074-273235641D61Q48047291-4FEF5BDF-7ED4-4C3D-B0C2-828B11BAF44AQ48360550-79B71807-CC84-4E82-832D-5546DF01614DQ48941494-6D2EB7E5-29AE-45E5-94A0-95D2201774CBQ49188150-3BEBD76F-6C34-4A58-A98E-E83D296498F1Q49884887-99931709-48A0-43D6-A25F-910163EC194E
P2860
Myeloid-derived suppressor cells in cancer: therapeutic, predictive, and prognostic implications
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Myeloid-derived suppressor cel ...... e, and prognostic implications
@ast
Myeloid-derived suppressor cel ...... e, and prognostic implications
@en
Myeloid-derived suppressor cel ...... e, and prognostic implications
@nl
type
label
Myeloid-derived suppressor cel ...... e, and prognostic implications
@ast
Myeloid-derived suppressor cel ...... e, and prognostic implications
@en
Myeloid-derived suppressor cel ...... e, and prognostic implications
@nl
prefLabel
Myeloid-derived suppressor cel ...... e, and prognostic implications
@ast
Myeloid-derived suppressor cel ...... e, and prognostic implications
@en
Myeloid-derived suppressor cel ...... e, and prognostic implications
@nl
P2093
P2860
P3181
P1433
P1476
Myeloid-derived suppressor cel ...... e, and prognostic implications
@en
P2093
Alberto J. Montero
C. Marcela Diaz-Montero
P2860
P304
P3181
P356
10.1053/J.SEMINONCOL.2014.02.003
P407
P577
2014-04-01T00:00:00Z